Edward LeCluyse is a Chief Scientist in the LifeSciences Division at LifeNet Health and is a faculty member at The University of North Carolina at Chapel Hill. Dr. LeCluyse has over 25 years of experience in in vitro pharmacology and toxicology, has held industry positions at Merck, CellzDirect, and Invitrogen, and academic positions at The Hamner Institutes for Health Sciences and UNC’s Eshelman School of Pharmacy. His research has focused on the isolation of primary liver cells from both normal and diseased tissues and the development of novel in vitro human hepatic models. Dr. LeCluyse is the author of over 100 publications and has presented extensively on hepatocyte biology, mechanisms of enzyme induction and DILI, and in vitro hepatic culture model systems.